GERMANTOWN, Md., Sept. 19, 2013 /PRNewswire/ -- Intrexon Corporation (XON), a leader in synthetic biology, today announced financial results for the second quarter of 2013.
Second Quarter Highlights
Highlights for the second quarter of 2013 include:
•Net loss decreased $10 million, or 60%, to $6.5 million for the quarter ended June 30, 2013
Help employers find you! Check out all the jobs and post your resume.
